122 related articles for article (PubMed ID: 12091475)
1. Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue.
Zhu MY; Kim CH; Hwang DY; Baldessarini RJ; Kim KS
J Neurochem; 2002 Jul; 82(1):146-53. PubMed ID: 12091475
[TBL] [Abstract][Full Text] [Related]
2. Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue.
Zhu MY; Wang WP; Baldessarini RJ; Kim KS
Brain Res Mol Brain Res; 2005 Feb; 133(2):167-75. PubMed ID: 15710233
[TBL] [Abstract][Full Text] [Related]
3. Effects of desipramine treatment on stress-induced up-regulation of norepinephrine transporter expression in rat brains.
Fan Y; Chen P; Li Y; Ordway GA; Zhu MY
Psychopharmacology (Berl); 2015 Jan; 232(2):379-90. PubMed ID: 25038868
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment.
Szot P; Ashliegh EA; Kohen R; Petrie E; Dorsa DM; Veith R
Brain Res; 1993 Aug; 618(2):308-12. PubMed ID: 8374761
[TBL] [Abstract][Full Text] [Related]
5. Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via alpha 2 receptors.
Shores MM; Szot P; Veith RC
Brain Res Mol Brain Res; 1994 Dec; 27(2):337-41. PubMed ID: 7898321
[TBL] [Abstract][Full Text] [Related]
6. Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.
Erickson SL; Gandhi AR; Asafu-Adjei JK; Sampson AR; Miner L; Blakely RD; Sesack SR
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1219-32. PubMed ID: 21208501
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the norepinephrine transporter by chronic administration of antidepressants.
Benmansour S; Altamirano AV; Jones DJ; Sanchez TA; Gould GG; Pardon MC; Morilak DA; Frazer A
Biol Psychiatry; 2004 Feb; 55(3):313-6. PubMed ID: 14744474
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors.
Zhu MY; Ordway GA
J Neurochem; 1997 Jan; 68(1):134-41. PubMed ID: 8978719
[TBL] [Abstract][Full Text] [Related]
9. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo.
Weinshenker D; White SS; Javors MA; Palmiter RD; Szot P
Brain Res; 2002 Aug; 946(2):239-46. PubMed ID: 12137927
[TBL] [Abstract][Full Text] [Related]
10. Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.
Zavosh A; Schaefer J; Ferrel A; Figlewicz DP
Brain Res Bull; 1999 Jul; 49(4):291-5. PubMed ID: 10424850
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Lacroix D; Blier P; Curet O; de Montigny C
J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo.
Heidbreder CA; Bianchi M; Lacroix LP; Faedo S; Perdona E; Remelli R; Cavanni P; Crespi F
Synapse; 2003 Dec; 50(4):269-76. PubMed ID: 14556231
[TBL] [Abstract][Full Text] [Related]
13. Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine.
Mateo Y; Pineda J; Meana JJ
J Neurochem; 1998 Aug; 71(2):790-8. PubMed ID: 9681471
[TBL] [Abstract][Full Text] [Related]
14. Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine beta-hydroxylase in the locus coeruleus and adrenal glands of rats.
Zhu MY; Wang WP; Iyo AH; Ordway GA; Kim KS
J Neurochem; 2005 Aug; 94(3):828-38. PubMed ID: 16033425
[TBL] [Abstract][Full Text] [Related]
15. Cellular iron concentrations directly affect the expression levels of norepinephrine transporter in PC12 cells and rat brain tissue.
Beard JL; Wiesinger JA; Jones BC
Brain Res; 2006 May; 1092(1):47-58. PubMed ID: 16650837
[TBL] [Abstract][Full Text] [Related]
16. The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.
Zhu MY; Kyle PB; Hume AS; Ordway GA
Neurochem Res; 2004 Feb; 29(2):419-27. PubMed ID: 15002740
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.
Mitchell NC; Bowman MA; Gould GG; Koek W; Daws LC
J Pharmacol Exp Ther; 2017 Jan; 360(1):84-94. PubMed ID: 27831486
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of the norepinephrine transporter in cultured rat astrocytes.
Inazu M; Takeda H; Matsumiya T
J Neurochem; 2003 Jan; 84(1):136-44. PubMed ID: 12485410
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine hydroxylase and norepinephrine transporter mRNA levels increase in locus coeruleus after coitus in rabbits.
Yang SP; Pau KY; Spies HG
J Mol Endocrinol; 1997 Dec; 19(3):311-9. PubMed ID: 9460652
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.
Zhao Z; Baros AM; Zhang HT; Lapiz MD; Bondi CO; Morilak DA; O'Donnell JM
Neuropsychopharmacology; 2008 Dec; 33(13):3190-200. PubMed ID: 18418364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]